Chemoinformaics analysis of 6-O-Acetylarbutin
| Molecular Weight | 314.29 | nRot | 4 |
| Heavy Atom Molecular Weight | 296.146 | nRig | 13 |
| Exact Molecular Weight | 314.1 | nRing | 2 |
| Solubility: LogS | -1.517 | nHRing | 1 |
| Solubility: LogP | -0.662 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 41.7983 |
| nHD | 4 | BPOL | 24.1337 |
| QED | 0.529 |
| Synth | 3.411 |
| Natural Product Likeliness | 1.933 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.088 |
| HIA | 0.859 |
| CACO-2 | -5.823 |
| MDCK | 0.000185992 |
| BBB | 0.627 |
| PPB | 0.214051 |
| VDSS | 0.376 |
| FU | 0.697671 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.043 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.233 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.397 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.306 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.06 |
| CL | 2.308 |
| T12 | 0.658 |
| hERG | 0.027 |
| Ames | 0.425 |
| ROA | 0.168 |
| SkinSen | 0.058 |
| Carcinogencity | 0.852 |
| EI | 0.031 |
| Respiratory | 0.024 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.852686 |